Search
for
Sort by
Research 31–60 of 1000+
- Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
- Comparison of disease severity and ultrasonographic abdominal subcutaneous fatty tissue thickness in hirsute women
- Findings from the assessment of real-world disease characteristics and outcomes in alopecia areata in a global non-interventional observational cohort (ADAAGIO) study
- Association Between Oxidative Stress Biomarkers And Clinical Severity Of Alopecia Areata: A Systematic Review
- Serum IL-21 Level and Its Relation to Activity and Severity of Alopecia Areata
- PD-1+CXCR5−CD4+T cells are correlated with the severity of systemic lupus erythematosus
- Cellular retinol‐binding protein‐1 expression increases with increasing clinical severity of alopecia areata
- Serum Epidermal Growth Factor Level and its Relation to Severity of Alopecia Areata
- Serum vitamin D level and disease severity of alopecia areata: A meta-regression analysis
- Serum level of retinol-binding protein 4 in alopecia areata: relation with recurrence and severity
- Hair Manganese as a Marker of Cardiometabolic Status Rather than Coronary Artery Disease Severity—An Exploratory Pilot Study
- BH08 Evaluating quality-of-life measures for alopecia: a comparative analysis of Dermatology Life Quality Index and Hospital Anxiety and Depression Scale correlations with disease severity
- Cross sectional quality of life assessment in patients with androgenetic alopecia
- Deficient and/or insufficient serum 25 hydroxy vitamin D in patients with alopecia areata: is it a fact or a fiction?
- Comparison of Efficacy of Oral Tofacitinib Versus Oral Minoxidil in Patients with Alopecia Areata
- Safety and efficacy of the JAK inhibitor tofacitinib citrate in patients with alopecia areata
- Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Serum interleukin-37 and its gene polymorphism (rs3811047) in Egyptian patients with alopecia areata
- When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials
- Study on Serum Vitamin D in Alopecia Areata Patients
- Correlation between serum granulysin level and clinical activity in patients with alopecia areata before and after tofacitinib therapy
- Comparative Evaluation of Oral Baricitinib and Tofacitinib in Alopecia Areata: A Retrospective Cohort Study Based on SALT Scores
- Dupilumab's Bidirectional Effects on Alopecia Areata: A Systematic Review
- Is the severity of alopecia areata associated with arterial stiffness?
- Comparative Efficacy of Microneedling with and without Topical Vitamin D3 in Localized Alopecia areata
- Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort
- Targeting the Janus Kinase Family in Autoimmune Skin Diseases
- High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease
- Moving Beyond Boundaries: Utilization of Longitudinal Exposure–Response Model for Bounded Outcome Score to Inform Decision Making in the Accelerated Drug Development Paradigm